Omnicell names Perry Genova as Chief Technology Officer

Omnicell (OMCL) announced that Perry A. Genova, PhD, will join the Company as Senior Vice President, Chief Technology Officer, effective March 31, 2025. In this role, Dr. Genova will lead Omnicell’s technology strategy as the Company works to address pressing issues within medication and supply management across all care settings in an effort to help customers move closer to the industry-defined vision of the Autonomous Pharmacy.